Filing Details

Accession Number:
0001209191-22-008981
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-02-11 18:09:14
Reporting Period:
2022-02-09
Accepted Time:
2022-02-11 18:09:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1595893 Turning Point Therapeutics Inc. TPTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1341011 Annette North 10628 Science Center Drive
San Diego CA 92121
Evp & General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-02-09 669 $36.30 11,696 No 4 S Direct
Common Stock Acquisiton 2022-02-09 16,283 $0.00 27,979 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 A Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Acquisiton 2022-02-09 58,600 $0.00 58,600 $37.68
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
58,600 2032-02-08 No 4 A Direct
Footnotes
  1. Sale of shares of common stock to cover tax withholding obligations associated with the vesting of a restricted stock unit award granted to Reporting Person on February 8, 2021.
  2. Represents restricted stock unit award granted under the Issuer's 2019 Equity Plan.
  3. 1/48th of the shares vest monthly following February 9, 2022.